BPG is committed to discovery and dissemination of knowledge
Citation
Xu S, Zhu Z, Shi PH, Xu YT, Zhang HM, Zheng Y, Chen YT, Lu GR, Zheng BJ. Letter to the Editor: Targeting the IGF2BP3/FBXO32/cGMP-PKG axis as a therapeutic modality for gastric cancer: A promising strategy. World J Gastroenterol 2026; 32(21): 116467 [DOI: 10.3748/wjg.v32.i21.116467]
Please LOGIN to submit a new comment.